Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution | RobinsPost News & Noticias

Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'


A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ... Read More

Pfizer's COVID-19 vaccine: What are the side effects? Who will get it first? Here's what we know


The US Food and Drug Administration has issued emergency use authorization (EUA) for the Covid-19 vaccine developed by Pfizer and BioNTech. After months of development, emergency use was authorized ... Read More

FDA investigating whether coronavirus vaccines are linked to deaths


The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across all age ranges. “FDA is doing a thorough investigation, across ... Read More

CDC advisers to review data on Pfizer-BioNTech COVID-19 vaccine


(Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote ... Read More

White House Threatens to Fire FDA Chief Unless Pfizer Covid Vaccine Approved Friday, Reports Say


White House chief of staff Mark Meadows told the head of the Food and Drug Administration to submit his resignation if the agency doesn't clear Pfizer's coronavirus vaccine for emergency use by day's ... Read More

FDA intends to put its most serious warning on Covid vaccines, sources say


The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans. Read More

FDA Approves Pfizer's Coronavirus Vaccine for Emergency Use


WASHINGTON (AP/CBS13) -- The U.S. has given the final go-ahead to the nation's first COVID-19 vaccine, launching emergency vaccinations in a bid to end the pandemic. After Friday's decision by the ... Read More

Pfizer is still struggling to replace its COVID revenue. Here's what we could see from the pharmaceutical giant in 2026.


Pfizer is still struggling to replace its COVID revenue. Here's what we could see from the pharmaceutical giant in 2026. Pfizer's coronavirus-related sales have fallen sharply -- and they may decline ... Read More

Pfizer files for emergency authorization of its COVID-19 vaccine for kids under 5


Pfizer filed with the Food and Drug Administration for authorization of its COVID-19 vaccine for young children on Tuesday. The emergency authorization would include children who range in age from 6 ... Read More

Covid-19 vaccination substantially lowered risks for children last season, CDC report says


Children who were vaccinated against Covid-19 last season had a “substantially lower risk” of emergency department and urgent care visits related to the virus, according to a report published Thursday ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus